Electroencephalography (EEG) provides a non-invasive, highly accessible, and cost-effective approach for detecting Alzheimer's disease (AD). However, existing methods, whether based on handcrafted feature engineering or standard deep learning, face three major challenges: 1) the lack of large-scale EEG-based AD datasets for robust representation learning; 2) limited generalizability across subjects; and 3) difficulty in adapting to highly heterogeneous data. To address these challenges, we curate the world's largest EEG-AD corpus to date, comprising 2,238 subjects. Leveraging this unique resource, we propose LEAD, the first large-scale foundation model for EEG-based AD detection. Specifically, we design a gated temporal-spatial Transformer that can adapt to EEG recordings with arbitrary lengths, channel configurations, and sampling rates. In addition, we introduce a subject-regularized training strategy to enhance subject-level feature learning. We further employ medical contrastive learning for pre-training on 13 datasets, including 4 AD datasets and 9 non-AD neurological disorder datasets, and fine-tune/test the model on the other 5 AD datasets. LEAD achieves the best average ranking across all 20 evaluations on 5 downstream datasets, substantially outperforming existing approaches, including state-of-the-art (SOTA) EEG foundation models. These results strongly demonstrate the effectiveness and practical potential of the proposed method for real-world EEG-based AD detection. Source code: https://github.com/DL4mHealth/LEAD
翻译:脑电图(EEG)为检测阿尔茨海默病(AD)提供了一种非侵入性、高度可及且成本效益高的方法。然而,现有方法无论是基于手工特征工程还是标准深度学习,都面临三大挑战:1)缺乏用于稳健表征学习的大规模基于EEG的AD数据集;2)跨被试的泛化能力有限;3)难以适应高度异质的数据。为应对这些挑战,我们构建了迄今为止全球最大的EEG-AD数据集,包含2,238名被试。利用这一独特资源,我们提出了LEAD,首个用于基于EEG的AD检测的大规模基础模型。具体而言,我们设计了一种门控时空Transformer,能够适应任意长度、通道配置和采样率的EEG记录。此外,我们引入了一种被试正则化训练策略以增强被试层面的特征学习。我们进一步采用医学对比学习在13个数据集上进行预训练,其中包括4个AD数据集和9个非AD神经系统疾病数据集,并在另外5个AD数据集上对模型进行微调/测试。LEAD在5个下游数据集的所有20项评估中取得了最佳平均排名,显著优于现有方法,包括最先进的(SOTA)EEG基础模型。这些结果有力地证明了所提方法在现实世界基于EEG的AD检测中的有效性和实际潜力。源代码:https://github.com/DL4mHealth/LEAD